InterCure

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest-growing cannabis company outside of North America. Canndoc, a wholly-owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first companies to offer Good Manufacturing Practice (GMP) certified, pharmaceutical-grade medical cannabis products. Leveraging its market-leading distribution network, top-tier international partnerships, and a high-margin vertically integrated "seed-to-sale" model, InterCure is spearheading the fastest-growing global cannabis markets outside of North America.